Drug Metabolite
Drug metabolite results when a drug is metabolized into a modified form which continues to produce effects. Drug metabolism redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.
Products Related to Drug Metabolite(546)
- GC45020TetrachlorohydroquinoneCAS: 87-87-6Purity: >98.00%
Tetrachlorohydroquinone (TCHQ) is a metabolite of the organochlorine biocide pentachlorophenol.
- GC45137Valproic Acid Acyl-D-GlucuronidePurity: >95.00%
Valproic acid acyl-D-glucuronide is the major urinary metabolite of valproic acid.
- GC45144Vildagliptin carboxylic acid metabolite (trifluoroacetate salt)CAS: 565453-41-0Purity: >98.00%
Vildagliptin carboxylic acid metabolite is the major metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor vildagliptin in humans.
- GC45151Voriconazole N-oxideCAS: 618109-05-0Purity: >95.00%
Voriconazole N-oxide is a major metabolite of the triazole antifungal voriconazole.
- GC45208α-hydroxy MetoprololCAS: 56392-16-6Purity: >98.00%
α-hydroxy Metoprolol is an active metabolite of the β1-adrenergic receptor blocker metoprolol.
- GC45252(-)-Sitagliptin Carbamoyl GlucuronideCAS: 940002-59-5Purity: >90.00%
(-)-Sitagliptin carbamoyl glucuronide is a minor phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (-)-sitagliptin.
- GC45650Des(benzylpyridyl) AtazanavirCAS: 1192224-24-0Purity: >98.00%
Le dé(benzylpyridyl) atazanavir (composé M1) est un produit de N-désalkylation du métabolite de l'atazanavir.
- GC45687Dasatinib N-oxideCAS: 910297-52-8Purity: >95.00%
Le N-oxyde de dasatinib est un métabolite mineur du dasatinib. Le dasatinib est un inhibiteur double Src/Bcr-Abl puissant et actif par voie orale.
- GC46284(±)-Cotinine-d3CAS: 110952-70-0Purity: >99.00%
An internal standard for the quantification of cotinine
- GC463871,3,7-Trimethyluric Acid-d9CAS: 117490-42-3Purity: >99.00%
An internal standard for the quantification of 1,3,7-trimethyluric acid
- GC465082',2'-Difluoro-2'-deoxyuridineCAS: 114248-23-6Purity: >95.00%
An active metabolite of gemcitabine
- GC465833-Amino-2,6-PiperidinedioneCAS: 2353-44-8Purity: >95.00%
An active metabolite of (±)-thalidomide
- GC47040Carebastine-d5CAS: 1189661-02-6Purity: >99.00%
An internal standard for the quantification of carebastine
- GC47193Desethyl Hydroxychloroquine-d4CAS: 1854126-47-8Purity: >99.00%
An internal standard for the quantification of desethyl hydroxychloroquine
- GC47195Desethylchloroquine-d4CAS: 1189971-72-9Purity: >99.00%
An internal standard for the quantification of desethylchloroquine
- GC47196Desloratadine-d4CAS: 2713301-38-1Purity: >99.00%
A neuropeptide with diverse biological activities
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC45020 | Tetrachlorohydroquinone | 87-87-6 | >98.00% | |
Tetrachlorohydroquinone (TCHQ) is a metabolite of the organochlorine biocide pentachlorophenol. | ||||
| GC45137 | Valproic Acid Acyl-D-Glucuronide | - | >95.00% | |
Valproic acid acyl-D-glucuronide is the major urinary metabolite of valproic acid. | ||||
| GC45144 | Vildagliptin carboxylic acid metabolite (trifluoroacetate salt) | 565453-41-0 | >98.00% | |
Vildagliptin carboxylic acid metabolite is the major metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor vildagliptin in humans. | ||||
| GC45151 | Voriconazole N-oxide | 618109-05-0 | >95.00% | |
Voriconazole N-oxide is a major metabolite of the triazole antifungal voriconazole. | ||||
| GC45208 | α-hydroxy Metoprolol | 56392-16-6 | >98.00% | |
α-hydroxy Metoprolol is an active metabolite of the β1-adrenergic receptor blocker metoprolol. | ||||
| GC45252 | (-)-Sitagliptin Carbamoyl Glucuronide | 940002-59-5 | >90.00% | |
(-)-Sitagliptin carbamoyl glucuronide is a minor phase II metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor (-)-sitagliptin. | ||||
| GC45385 | Ara-G | 38819-10-2 | >95.00% | |
| ||||
| GC45390 | Benazepril Acyl-β-D-Glucuronide | - | >95.00% | |
| ||||
| GC45449 | Erythromycylamine | 26116-56-3 | >95.00% | |
| ||||
| GC45508 | MEGX (hydrochloride) | 7729-94-4 | >95.00% | |
| ||||
| GC45580 | Tizoxanide-d4 | 1246817-56-0 | >99.00% | |
| ||||
| GC45650 | Des(benzylpyridyl) Atazanavir | 1192224-24-0 | >98.00% | |
Le dé(benzylpyridyl) atazanavir (composé M1) est un produit de N-désalkylation du métabolite de l'atazanavir. | ||||
| GC45687 | Dasatinib N-oxide | 910297-52-8 | >95.00% | |
Le N-oxyde de dasatinib est un métabolite mineur du dasatinib. Le dasatinib est un inhibiteur double Src/Bcr-Abl puissant et actif par voie orale. | ||||
| GC45969 | 6β-hydroxy Eplerenone | 209253-80-5 | >95.00% | |
A major metabolite of eplerenone | ||||
| GC46284 | (±)-Cotinine-d3 | 110952-70-0 | >99.00% | |
An internal standard for the quantification of cotinine | ||||
| GC46387 | 1,3,7-Trimethyluric Acid-d9 | 117490-42-3 | >99.00% | |
An internal standard for the quantification of 1,3,7-trimethyluric acid | ||||
| GC46471 | 17β-hydroxy Exemestane-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46508 | 2',2'-Difluoro-2'-deoxyuridine | 114248-23-6 | >95.00% | |
An active metabolite of gemcitabine | ||||
| GC46539 | 2-Chloroadenine | 1839-18-5 | >98.00% | |
A heterocyclic building block | ||||
| GC46583 | 3-Amino-2,6-Piperidinedione | 2353-44-8 | >95.00% | |
An active metabolite of (±)-thalidomide | ||||
| GC47040 | Carebastine-d5 | 1189661-02-6 | >99.00% | |
An internal standard for the quantification of carebastine | ||||
| GC47193 | Desethyl Hydroxychloroquine-d4 | 1854126-47-8 | >99.00% | |
An internal standard for the quantification of desethyl hydroxychloroquine | ||||
| GC47195 | Desethylchloroquine-d4 | 1189971-72-9 | >99.00% | |
An internal standard for the quantification of desethylchloroquine | ||||
| GC47196 | Desloratadine-d4 | 2713301-38-1 | >99.00% | |
A neuropeptide with diverse biological activities | ||||